VBI Vaccines, Inc.【VBIV】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24
売上高 127 344 193 201 178 234 259 2,684 360 640 647 574 415 184 298 164 301 142 107 81 126 346 317 293 485 720 6,624 853 1,214
売上成長率(%) - - - - 284.9 108.1 1989.6 191.1 150.3
売上原価 1,275 1,357 1,334 1,227 1,413 1,067 801 1,228 988 2,354 1,977 2,585 2,577 2,060 2,111 2,421 - - - - - - - - - - - - -
研究開発費 4,654 4,528 5,205 6,531 6,964 10,914 10,507 10,082 9,227 7,361 5,401 4,343 3,193 2,365 4,478 4,824 6,839 4,582 2,972 5,166 2,362 5,643 4,983 2,518 3,151 3,292 1,532 1,368 2,571
販売管理費 - - - - - - - - - - - - - - - - - - - - - - - - 13,284 10,917 9,036 8,906 7,671
営業費用 8,974 8,656 -9,334 65,109 11,802 15,968 14,801 21,193 14,179 12,909 16,790 10,742 9,828 8,326 12,151 14,376 15,998 16,583 15,131 20,953 16,046 23,249 21,875 21,732 19,994 37,692 16,693 14,217 12,966
営業利益 -8,847 -8,312 -9,141 -10,980 -11,624 -15,734 -14,542 -18,509 -13,819 -12,269 -16,143 -10,168 -9,413 -8,142 -11,853 -14,212 -15,697 -16,441 -15,024 -20,872 -15,920 -22,903 -21,558 -21,439 -19,509 -36,972 -10,069 -13,364 -11,752
営業利益率 (%) -4022.5 -5135 -152.0 -1566.7 -968.0
経常(税引前)利益 -9,069 -9,013 -9,802 -11,543 -12,251 -16,731 -15,370 -19,250 -14,606 -13,170 -16,162 -10,875 -8,358 -9,513 -12,997 -15,362 -17,647 -17,476 -15,847 -18,783 -21,254 -45,699 -25,209 -21,141 -27,751 -44,628 -20,444 -13 -17,900
経常(税引前)利益率(%) -7140.9 -2620.1 -5078.8 -5742.8 -6882.6 -7150 -5934.4 -717.2 -4057.2 -2057.8 -2498.0 -1894.6 -2014.0 -5170.1 -4361.4 -9367.1 -5862.8 -12307.0 -14810.3 -23188.9 -16868.3 -13207.8 -7952.4 -7215.4 -5721.9 -6198.3 -308.6 -1.5 -1474.5
法人税等合計 -431 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -8,638 -9,013 -9,802 -11,542 -12,251 -16,731 -15,370 -19,250 -14,606 -13,170 -16,162 -10,875 -8,358 -9,513 -12,997 -15,362 -17,647 -17,476 -15,847 -18,783 -21,254 -45,699 -25,209 -21,141 -27,751 -44,628 -20,444 -13 -17,900
純利益率(%) -5721.9 -6198.3 -308.6 -1.5 -1474.5
一株あたり利益 - - - - - - - - - - - - - - - - - - - - -0.08 -0.18 -0.1 -0.08 -3.22 -5.18 -1.01 1.27 -0.73
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - -0.08 -0.18 -0.1 -0.08 -3.22 -5.18 -1.01 1.27 -0.73
EBITDA -19,001 -36,462 -9,571 -12,890 -11,259
EBITDAマージン(%) -3917.7 -5064.2 -144.5 -1511.1 -927.4